Literature DB >> 19261353

Role of antibodies in controlling dengue virus infection.

Hilde M van der Schaar1, Jan C Wilschut, Jolanda M Smit.   

Abstract

The incidence and disease burden of arthropod-borne flavivirus infections have dramatically increased during the last decades due to major societal and economic changes, including massive urbanization, lack of vector control, travel, and international trade. Specifically, in the case of dengue virus (DENV), the geographical spread of all four serotypes throughout the subtropical regions of the world has led to larger and more severe outbreaks. Many studies have established that recovery from infection by one DENV serotype provides immunity against that serotype, whereas reinfection with another serotype may result in severe disease. Pre-existing antibodies thus play a critical role in controlling viral infection. Both neutralization and enhancement of DENV infection by antibodies are thought to be related to the natural route of viral entry into cells. In this review, we will describe the current knowlegde on the mechanisms involved in flavivirus cell entry and discuss how antibodies may influence the course of infection towards neutralization or enhancement of viral disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19261353     DOI: 10.1016/j.imbio.2008.11.008

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  13 in total

1.  Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors.

Authors:  Nadine Dalrymple; Erich R Mackow
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

2.  Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.

Authors:  Kuan Rong Chan; Summer Li-Xin Zhang; Hwee Cheng Tan; Ying Kai Chan; Angelia Chow; Angeline Pei Chiew Lim; Subhash G Vasudevan; Brendon J Hanson; Eng Eong Ooi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

Review 3.  Dengue virus life cycle: viral and host factors modulating infectivity.

Authors:  Izabela A Rodenhuis-Zybert; Jan Wilschut; Jolanda M Smit
Journal:  Cell Mol Life Sci       Date:  2010-04-06       Impact factor: 9.261

Review 4.  The relationship of interacting immunological components in dengue pathogenesis.

Authors:  David G Nielsen
Journal:  Virol J       Date:  2009-11-27       Impact factor: 4.099

5.  Differential expression of Toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease.

Authors:  Silvia Torres; Juan Carlos Hernández; Diana Giraldo; Margarita Arboleda; Mauricio Rojas; Jolanda M Smit; Silvio Urcuqui-Inchima
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

Review 6.  Current progress in dengue vaccines.

Authors:  Shu-Wen Wan; Chiou-Feng Lin; Shuying Wang; Yu-Hung Chen; Trai-Ming Yeh; Hsiao-Sheng Liu; Robert Anderson; Yee-Shin Lin
Journal:  J Biomed Sci       Date:  2013-06-13       Impact factor: 8.410

7.  Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus.

Authors:  Chonlatip Pipattanaboon; Tadahiro Sasaki; Mitsuhiro Nishimura; Chayanee Setthapramote; Pannamthip Pitaksajjakul; Pornsawan Leaungwutiwong; Kriengsak Limkittikul; Orapim Puiprom; Mikiko Sasayama; Panjaporn Chaichana; Tamaki Okabayashi; Takeshi Kurosu; Ken-Ichiro Ono; Pongrama Ramasoota; Kazuyoshi Ikuta
Journal:  Biologics       Date:  2013-08-15

8.  Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement.

Authors:  Chen-Yi Chiang; Chien-Hsiung Pan; Chun-Hsiang Hsieh; Jy-Ping Tsai; Mei-Yu Chen; Hsueh-Hung Liu; Shih-Jen Liu; Pele Chong; Chih-Hsiang Leng; Hsin-Wei Chen
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19

9.  Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.

Authors:  Panjaporn Chaichana; Tamaki Okabayashi; Orapim Puiprom; Mikiko Sasayama; Tadahiro Sasaki; Akifumi Yamashita; Pongrama Ramasoota; Takeshi Kurosu; Kazuyoshi Ikuta
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

10.  Modelling Virus and Antibody Dynamics during Dengue Virus Infection Suggests a Role for Antibody in Virus Clearance.

Authors:  Hannah E Clapham; Than Ha Quyen; Duong Thi Hue Kien; Ilaria Dorigatti; Cameron P Simmons; Neil M Ferguson
Journal:  PLoS Comput Biol       Date:  2016-05-23       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.